Skip to main content
For Employers, Advisors, and Procurement Teams

We sell the labor of containment.

You get defensible containment decisions and CFO-ready packets, not another dashboard.

Simulation ranges, assumption-bound, and auditable.

Representative bounded exposure analysis artifact
Representative preview. Video available on request.

What this is

  • +Bounded scenario modeling (ranges)
  • +Governed decisions (controls + approvals)
  • +CFO-ready artifacts (packets, logs)

What this is not

  • xDiagnosis or medical advice
  • xGuaranteed savings
  • xA generic analytics dashboard

GLP-1 costs do not fail slowly.

Cost of inaction: one renewal cycle without bounded controls can force unplanned GLP-1 spend variance into operating budgets before contracts can reset.

Unlike PBM step-therapy programs that only gate utilization, this operating model replaces manual containment labor with governed re-analysis and artifact delivery.

Non-linear scale

Costs scale non-linearly as awareness and eligibility expand simultaneously, outstripping traditional actuarial projections.

Compounding decisions

Every coverage decision compounds, creating long-term liabilities often hidden within quarterly pharmacy rebate cycles.

Hard reversals

Once spend escapes, it is politically and operationally hard to reverse. Intervention must be clinical and governed, not just administrative.

We replace ongoing GLP-1 cost management labor.

This is not software to monitor. This is not advisory-only. We replace the operational burden of managing metabolic volatility.

Bounded Health Institutional Artifact

Tangible outputs.

We produce the documents that justify decisions. From audit trails to outcome reports, the output is designed for procurement, legal, and executive review.

Quick example (illustrative)

A simple view of what executives get, without drowning in numbers.

Illustrative

Pilot cohort

1,000 members

Exposure range reduction

15-35%

What stayed constant

  • -Baseline policy set
  • -Eligibility assumptions

What changed

  • ->Taper protocol applied
  • ->Exception rules enforced

Every output includes assumptions, bounds, and an audit trail.

Illustrative only. Outcomes vary by cohort profile, policy design, and adherence.

Operating Model

Governed containment.

Designed to fit existing pharmacy benefit workflows through staged integration and governed handoffs.

/01

Cost exposure is analyzed conservatively

We quantify your current trajectory with clinical precision, establishing a baseline that accounts for adherence, comorbidities, and metabolic stability.

/02

Governed re-analysis runs periodically

Re-analysis runs within approved policy bounds on a defined cadence, with assumptions and thresholds documented.

/03

GLP-1 containment is managed through governed delivery

Coordination is supported through governed artifact delivery and exception alerts under approved protocols.

/04

The system operates quietly in the background

No new dashboards to monitor. Value is delivered through decision-ready artifacts and documented escalation paths.

Executive Deliverables

We do not provide dashboard logins. We provide decision-ready artifacts designed for the boardroom.

ART-01

Executive cost exposure summaries

Quarterly financial report for the CFO detailing realized savings, spend trajectory, and risk containment in basis points.

ART-02

Cohort stability and protocol adherence

Transparent documentation of clinical stability, confidence ranges, and protocol adherence status for governance review.

ART-03

Ongoing exception alerts

Notifications issued only when thresholds are crossed or policy intervention is required, ensuring silence during baseline operation.

ART-04

Periodic review packets

Comprehensive data for advisors to justify program value and adjust long-term portfolio strategy.

Responsibility boundaries are explicit.

Platform, advisor, and employer duties stay separated so decisions remain defensible under audit and procurement review.

Platform responsibility

Run bounded analyses, issue governance artifacts, and log exception decisions with timestamps and rationale.

Advisor responsibility

Own client policy communication, recommendation framing, and stakeholder alignment.

Employer responsibility

Approve policy bounds, authorize changes, and maintain accountable relationships with care and benefit administrators.

When reality deviates

Variance is treated as a governance signal. Escalation follows a documented path:

  1. Threshold breach is detected and logged.
  2. An exception alert is issued with bounded context.
  3. Review owners assess cause and approve next action.
  4. Outcome and rationale are added to the next governance packet.

What happens without bounds

Illustrative scenario ranges, not predictions.

Bounded vs Unbounded Cost Growth

Range bands showing potential exposure difference over 36 months

Illustrative

Chart showing two range bands: unbounded costs rising steeply from 100 to 395-565 over 36 months, while bounded costs remain relatively flat from 100 to 122-145

Illustrative. Simulation ranges, not predictions. Outcomes vary by program design and adherence.

Where Containment Comes From

Relative contribution of governance levers (illustrative proportions)

Illustrative

Horizontal bar chart showing containment contributions: Taper Governance 30%, Eligibility Policy 25%, Adherence Support 20%, Exception Handling 15%, Procurement Controls 10%

Illustrative. Simulation ranges, not predictions. Outcomes vary by program design and adherence.

Proof Loop Timeline

Quarterly governance cycle: run, monitor, detect, review, report

Illustrative

Timeline diagram with 5 steps: 1. Scenario Run with assumptions declared, 2. Monitoring with data refresh, 3. Variance Detection comparing actuals vs projected, 4. Governance Review with explanation and approval, 5. Quarterly Packet as CFO-ready output

Illustrative. Simulation ranges, not predictions. Outcomes vary by program design and adherence.

Bounded containment reduces exposure through governed decisions and controlled policy enforcement.

Simulation outputs are ranges and assumption-bound. Artifacts are designed to be defensible and auditable.

View Scope & Refusal Policy ->

Institutional Absence.

The mark of good infrastructure is that you do not notice it until it is missing. We are designed to be invisible.

- No dashboards to monitor
- No daily GLP-1 oversight
- No model tuning
- No operational babysitting
- No separate software rollout workstream

Built for advisors who carry real responsibility

Bounded Health is built exclusively for Pharmacy Benefit Consultants and Benefits Advisors who require measurable cost reduction for their clients.

/Pharmacy benefit consultants
/Employer benefits advisors
/Not for DIY teams
/Not for experimentation

"We do not sell software. We sell the labor of containment. If you are looking for a tool for internal management, we are not the right partner."

Example Artifacts

CFO-ready, audit-friendly

These are representative formats. Shared as mock/redacted examples.

  • -Outputs are simulation ranges, not predictions.
  • -Every packet includes assumptions, versioning, and a decision trail.
  • -We refuse out-of-scope requests and log governance actions.

Evidence of value (without marketing math)

Ranges, assumptions, and limits disclosed. No invented metrics.

We don't publish customer names or results without written approval.

Instead, we show representative artifact formats and clearly-labeled illustrative scenarios.

Illustrative Scenarios

Mid-market employer containment scenario

Illustrative scenario
Exposure range reduction
1535%per quarter
Exception rate reduction
2040%first 90 days
Approval cycle time
37days fasteraverage

Benefits advisor portfolio scenario

Illustrative scenario
Client retention improvement
1025%year-over-year
Variance explained
8595%within 14 days
CFO packet delivery
35days post-quarterconsistent

Evidence availability is explicitly bounded

We separate what is publicly available today from what is issued in controlled pilot and managed program contexts.

Available now

  • Representative artifact formats and mock/redacted packet structures.
  • Illustrative scenario ranges with assumptions and limits.
  • Public security, privacy, methodology, and scope policy pages.

Issued in controlled pilot context

  • Tenant-specific baseline exposure and quarterly variance packets.
  • Exception lifecycle artifacts with owner approvals and timestamps.
  • Program governance summaries under agreed operating bounds.

Due diligence resources

Procurement and legal review teams can start with structured materials before pilot scoping.

Change control is versioned and reviewed quarterly. Method updates are reflected in assumptions and governance packet notes.

Last reviewed: February 23, 2026

Governance & Trust

Built for institutional requirements

Security controls, data handling practices, and scope limits are designed for procurement, legal, and security review.

Role-Based Access Control

Access scoped by role and organization. Users see only what they're authorized to access.

Tenant Isolation

Employer data is logically isolated. Cross-tenant access is structurally prevented.

Audit Logging

High-stakes actions are logged with timestamp, actor, and rationale for governance review.

Data Minimization

We collect only what's required for bounded modeling. Cohort-level inputs, not individual records where possible.

Scope & Limits

  • Simulation outputs are ranges, not predictions.
  • Not medical advice or diagnosis.
  • Assumptions required for all outputs.
  • Control design is aligned to HIPAA Security Rule safeguards and SOC 2 trust service control domains.

Change Control

Method updates are versioned, reviewed on a quarterly governance cadence, and reflected in artifact assumptions.

Ready for a bounded pilot?

We'll review your program shape and show what the CFO packet looks like.

Review sample decision artifacts
Request due diligence documentation

After submission, we respond within one business day with a scoped evaluation path: security and legal review materials first, then a pilot-readiness workplan.

No medical advice. Simulation ranges, not predictions. Assumptions required.